108 related articles for article (PubMed ID: 1471943)
1. EGFR and HER-2 oncogenes expression in an experimental model of two-stage chemically induced carcinogenesis in mouse skin.
Diamantopoulou S; Yapijakis C; Papakosta V; Ebeling M; Lazaris AC; Derka S; Vylliotis A; Diamantopoulos P; Vairaktari G; Vassiliou S
J Craniomaxillofac Surg; 2024 Apr; 52(4):413-419. PubMed ID: 38443188
[TBL] [Abstract][Full Text] [Related]
2. Initiation of genetic instability and tumour formation: a review and hypothesis of a nongenotoxic mechanism.
Bignold LP
Cell Mol Life Sci; 2003 Jun; 60(6):1107-17. PubMed ID: 12861379
[TBL] [Abstract][Full Text] [Related]
3. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.
Lochhead P; Chan AT; Nishihara R; Fuchs CS; Beck AH; Giovannucci E; Ogino S
Mod Pathol; 2015 Jan; 28(1):14-29. PubMed ID: 24925058
[TBL] [Abstract][Full Text] [Related]
4. Decoding the basis of histological variation in human cancer.
Fujii M; Sekine S; Sato T
Nat Rev Cancer; 2024 Feb; 24(2):141-158. PubMed ID: 38135758
[TBL] [Abstract][Full Text] [Related]
5. Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.
Dou X; Tong P; Huang H; Zellmer L; He Y; Jia Q; Zhang D; Peng J; Wang C; Xu N; Liao DJ
J Cancer; 2020; 11(10):2887-2920. PubMed ID: 32226506
[TBL] [Abstract][Full Text] [Related]
6. The failure of rodent carcinogenesis as a model for Man.
Berry C
Toxicol Res (Camb); 2018 Jul; 7(4):553-557. PubMed ID: 30090605
[TBL] [Abstract][Full Text] [Related]
7. The molecular determinants of carcinogenesis.
Pitot HC
Symp Fundam Cancer Res; 1986; 39():187-96. PubMed ID: 3423469
[TBL] [Abstract][Full Text] [Related]
8. Host factors in the susceptibility of mice to tumour initiating and promoting agents.
Slaga TJ
IARC Sci Publ; 1983; (51):257-73. PubMed ID: 6365772
[TBL] [Abstract][Full Text] [Related]
9. Nakahara Memorial Lecture. Pathways of carcinogenesis--genetic and epigenetic.
Pitot HC; Dragan Y; Xu YH; Peterson J; Hully J; Campbell H
Princess Takamatsu Symp; 1991; 22():21-33. PubMed ID: 1844243
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic alterations as intermediate end points in chemoprevention studies.
Conti CJ; Gimenez-Conti IB
IARC Sci Publ; 1996; (139):249-60. PubMed ID: 8923035
[TBL] [Abstract][Full Text] [Related]
11. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
12. [Progression of tumors: etiologic, morphologic and molecular-biological aspects].
Turosov VS
Arkh Patol; 1992; 54(7):5-14. PubMed ID: 1471943
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
